Form 8-K - Current report:
SEC Accession No. 0001477932-24-006606
Filing Date
2024-10-22
Accepted
2024-10-22 07:27:59
Documents
16
Period of Report
2024-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K qron_8k.htm   iXBRL 8-K 33316
2 TERM SHEET qron_ex1037.htm EX-10.37 56773
  Complete submission text file 0001477932-24-006606.txt   213548

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qron-20241016.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qron-20241016_lab.xml EX-101.LAB 12618
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qron-20241016_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qron-20241016_pre.xml EX-101.PRE 7881
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qron-20241016_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT qron_8k_htm.xml XML 3413
Mailing Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101
Business Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101 212-945-2080
Qrons Inc. (Filer) CIK: 0001689084 (see all company filings)

EIN.: 813623646 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55800 | Film No.: 241384680
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)